-
1-{1-[(4-{7-phenyl-1H-imidazo[4,5-g]quinoxalin-6-yl}phenyl)methyl]piperidin-4-yl}-2,3-dihydro-1H-1,3-benzodiazol-2-one trifluoroacetic acid hydrate
-
ChemBase ID:
153848
-
Molecular Formular:
C36H32F3N7O4
-
Molecular Mass:
683.6789896
-
Monoisotopic Mass:
683.2467872
-
SMILES and InChIs
SMILES:
c1ccc(cc1)c1c(nc2cc3c(cc2n1)[nH]cn3)c1ccc(cc1)CN1CCC(CC1)n1c2ccccc2[nH]c1=O.C(=O)(C(F)(F)F)O.O
Canonical SMILES:
OC(=O)C(F)(F)F.O=c1[nH]c2c(n1C1CCN(CC1)Cc1ccc(cc1)c1nc3cc4nc[nH]c4cc3nc1c1ccccc1)cccc2.O
InChI:
InChI=1S/C34H29N7O.C2HF3O2.H2O/c42-34-39-26-8-4-5-9-31(26)41(34)25-14-16-40(17-15-25)20-22-10-12-24(13-11-22)33-32(23-6-2-1-3-7-23)37-29-18-27-28(36-21-35-27)19-30(29)38-33;3-2(4,5)1(6)7;/h1-13,18-19,21,25H,14-17,20H2,(H,35,36)(H,39,42);(H,6,7);1H2
InChIKey:
CRRPFKCJZALCLQ-UHFFFAOYSA-N
-
Cite this record
CBID:153848 http://www.chembase.cn/molecule-153848.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
|
IUPAC name
|
|
1-{1-[(4-{7-phenyl-1H-imidazo[4,5-g]quinoxalin-6-yl}phenyl)methyl]piperidin-4-yl}-2,3-dihydro-1H-1,3-benzodiazol-2-one trifluoroacetic acid hydrate
|
|
|
|
|
IUPAC Traditional name
|
|
1-{1-[(4-{7-phenyl-1H-imidazo[4,5-g]quinoxalin-6-yl}phenyl)methyl]piperidin-4-yl}-3H-1,3-benzodiazol-2-one trifluoroacetic acid hydrate
|
|
|
|
|
Synonyms
|
|
1,3-Dihydro-1-(1-((4-(6-phenyl-1H-imidazo[4,5-g]quinoxalin-7-yl)phenyl)methyl)-4-piperidinyl)-2H-benzimidazol-2-one trifluoroacetate salt hydrate
|
|
Akt Inhibitor VIII trifluoroacetate salt hydrate
|
|
Akti-1/2 trifluoroacetate salt hydrate
|
|
Akt1/2 kinase inhibitor
|
|
|
|
|
MDL Number
|
|
|
PubChem SID
|
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
|
Acid pKa
|
11.815566
|
H Acceptors
|
5
|
H Donor
|
2
|
LogD (pH = 5.5)
|
3.1382613
|
LogD (pH = 7.4)
|
5.1158957
|
Log P
|
5.6199303
|
Molar Refractivity
|
163.0057 cm3
|
Polarizability
|
67.3554 Å3
|
Polar Surface Area
|
90.04 Å2
|
Rotatable Bonds
|
6
|
Lipinski's Rule of Five
|
false
|
DETAILS
DETAILS
Sigma Aldrich
Sigma Aldrich -
A6730
|
Application Akt plays a role in signal transduction pathways of cell proliferation, apoptosis, angiogenesis, and diabetes. Akt1 and Akt2 dual kinase inhibitors are capable of sensitizing tumor cells to certain apoptotic stimuli, and inhibit Akt phosphorylation in vivo. Akt1 kinase activity and its regulation by extracellular signaling factors in vivo in hematopoietic cells suggests the activation of AKT1 involves intracellular translocation of the kinase from cytosol to membrane. Biochem/physiol Actions Isozyme selective Akt1/2 kinase inhibitor. In in vitro kinase assays, Akt1/2 kinase inhibitor shows IC50 = 58 nM, 210 nM, and 2.12 mM for Akt1, Akt2, and Akt3, respectively, The inhibition appears to be pleckstrin homology (PH) domain-dependent and the Akt1/2 kinase inhibitor has no inhibitory effect against PH domain-lacking Akts, or other closely related AGC family kinases, PKA, PKC, and SGK, even at concentrations as high as 50 μM. |
PATENTS
PATENTS
PubChem Patent
Google Patent